Cargando…

Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy

BACKGROUND: The Mre11-Rad50-Nbs1 (MRN) complex is well known for its crucial role in initiating DNA double strand breaks (DSBs) repair pathways to resistant irradiation (IR) injury and thus facilitating radioresistance which severely reduces radiocurability of nasopharyngeal cancer (NPC). Targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Lihong, Huang, Jiancong, Wang, Kai, Li, Jingjia, Yan, Ruicheng, Zhu, Ling, Ye, Jin, Wu, Xifu, Zhuang, Shimin, Li, Daqing, Zhang, Gehua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782334/
https://www.ncbi.nlm.nih.gov/pubmed/26951044
http://dx.doi.org/10.1186/s12885-016-2190-8
_version_ 1782419932292579328
author Chang, Lihong
Huang, Jiancong
Wang, Kai
Li, Jingjia
Yan, Ruicheng
Zhu, Ling
Ye, Jin
Wu, Xifu
Zhuang, Shimin
Li, Daqing
Zhang, Gehua
author_facet Chang, Lihong
Huang, Jiancong
Wang, Kai
Li, Jingjia
Yan, Ruicheng
Zhu, Ling
Ye, Jin
Wu, Xifu
Zhuang, Shimin
Li, Daqing
Zhang, Gehua
author_sort Chang, Lihong
collection PubMed
description BACKGROUND: The Mre11-Rad50-Nbs1 (MRN) complex is well known for its crucial role in initiating DNA double strand breaks (DSBs) repair pathways to resistant irradiation (IR) injury and thus facilitating radioresistance which severely reduces radiocurability of nasopharyngeal cancer (NPC). Targeting native cellular MRN function would sensitize NPC cells to IR. METHODS: A recombinant adenovirus containing a mutant Rad50 gene (Ad-RAD50) expressing Rad50 zinc hook domain but lacking the ATPase domain and the Mre11 interaction domain was constructed to disrupt native cellular MRN functions. The effects of Ad-RAD50 on the MRN functions were assessed in NPC cells lines using western blot, co-immunoprecipitation and confocal microscopy analyses. The increased radiosensitivity of transient Ad-RAD50 to IR was examined in NPC cells, including MTT assay, colony formation. The molecular mechanisms of radiosensitization were confirmed by neutral comet assay and western bolts. Nude mice subcutaneous injection, tumor growth curve and TUNEL assay were used to evaluate tumor regression and apoptosis in vivo. RESULTS: Rad50 is remarkably upregulated in NPC cells after IR, implying the critical role of Rad50 in MRN functions. The transient expression of this mutant Rad50 decreased the levels of native cellular Rad50, Mre11 and Nbs1, weakened the interactions among these proteins, abrogated the G2/M arrest induced by DSBs and reduced the DNA repair ability in NPC cells. A combination of IR and mutant RAD50 therapy produced significant tumor cytotoxicity in vitro, with a corresponding increase in DNA damage, prevented proliferation and cell viability. Furthermore, Ad-RAD50 sensitized NPC cells to IR by causing dramatic tumor regression and inducing apoptosis in vivo. CONCLUSION: Our findings define a novel therapeutic approach to NPC radiosensitization via targeted native cellular Rad50 disruption. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2190-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4782334
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47823342016-03-09 Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy Chang, Lihong Huang, Jiancong Wang, Kai Li, Jingjia Yan, Ruicheng Zhu, Ling Ye, Jin Wu, Xifu Zhuang, Shimin Li, Daqing Zhang, Gehua BMC Cancer Research Article BACKGROUND: The Mre11-Rad50-Nbs1 (MRN) complex is well known for its crucial role in initiating DNA double strand breaks (DSBs) repair pathways to resistant irradiation (IR) injury and thus facilitating radioresistance which severely reduces radiocurability of nasopharyngeal cancer (NPC). Targeting native cellular MRN function would sensitize NPC cells to IR. METHODS: A recombinant adenovirus containing a mutant Rad50 gene (Ad-RAD50) expressing Rad50 zinc hook domain but lacking the ATPase domain and the Mre11 interaction domain was constructed to disrupt native cellular MRN functions. The effects of Ad-RAD50 on the MRN functions were assessed in NPC cells lines using western blot, co-immunoprecipitation and confocal microscopy analyses. The increased radiosensitivity of transient Ad-RAD50 to IR was examined in NPC cells, including MTT assay, colony formation. The molecular mechanisms of radiosensitization were confirmed by neutral comet assay and western bolts. Nude mice subcutaneous injection, tumor growth curve and TUNEL assay were used to evaluate tumor regression and apoptosis in vivo. RESULTS: Rad50 is remarkably upregulated in NPC cells after IR, implying the critical role of Rad50 in MRN functions. The transient expression of this mutant Rad50 decreased the levels of native cellular Rad50, Mre11 and Nbs1, weakened the interactions among these proteins, abrogated the G2/M arrest induced by DSBs and reduced the DNA repair ability in NPC cells. A combination of IR and mutant RAD50 therapy produced significant tumor cytotoxicity in vitro, with a corresponding increase in DNA damage, prevented proliferation and cell viability. Furthermore, Ad-RAD50 sensitized NPC cells to IR by causing dramatic tumor regression and inducing apoptosis in vivo. CONCLUSION: Our findings define a novel therapeutic approach to NPC radiosensitization via targeted native cellular Rad50 disruption. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2190-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-07 /pmc/articles/PMC4782334/ /pubmed/26951044 http://dx.doi.org/10.1186/s12885-016-2190-8 Text en © Chang et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chang, Lihong
Huang, Jiancong
Wang, Kai
Li, Jingjia
Yan, Ruicheng
Zhu, Ling
Ye, Jin
Wu, Xifu
Zhuang, Shimin
Li, Daqing
Zhang, Gehua
Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
title Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
title_full Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
title_fullStr Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
title_full_unstemmed Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
title_short Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
title_sort targeting rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782334/
https://www.ncbi.nlm.nih.gov/pubmed/26951044
http://dx.doi.org/10.1186/s12885-016-2190-8
work_keys_str_mv AT changlihong targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy
AT huangjiancong targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy
AT wangkai targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy
AT lijingjia targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy
AT yanruicheng targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy
AT zhuling targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy
AT yejin targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy
AT wuxifu targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy
AT zhuangshimin targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy
AT lidaqing targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy
AT zhanggehua targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy